Hsu Jen Te, Tamai Hideo, Kyo Eisho, Tsuji Takafumi, Watanabe Satoshi
Chiayi Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan.
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):555-63. doi: 10.1002/ccd.22035.
The goal of this study was to compare the antegrade-approach and bilateral-approach strategies for chronic total occlusion (CTO).
The retrograde approach has been reported for difficult CTO lesions.
This study assessed 96 consecutive patients with 119 CTO lesions. The lesions were treated with either an antegrade approach (A group) or a combined bilateral antegrade and retrograde approach (B group). The specific intervention techniques, in-hospital success rate, and major adverse cardiac and cerebrovascular events (MACCE) were compared.
Lesions with well-developed septal collaterals with nontortuous microchannels were preferentially chosen for the B group versus A group (P < 0.001 and 0.008, respectively). Compared with the A group, there were more CTO lesions located in the right coronary artery in the B group (P < 0.001). In the B group, the CTO lesions had a longer length and needed stiffer wires for crossing than in the A group (P = 0.001 and 0.046, respectively). The technical success rate was 94% and 86% for the A group and the B group, respectively (P = 0.127). In-hospital complications were not different between the two groups. The B group needed a higher radiation exposure dose and a greater exposure time than the A group (P < 0.001). In the B group, use of the retrograde method significantly increased the final success rate.
These results suggest that all CTO lesions should first be managed with an antegrade approach. When there is difficulty crossing the lesion, switching to a bilateral approach is an option for lesions with well-developed collaterals.
本研究的目的是比较慢性完全闭塞(CTO)病变的顺行入路和双侧入路策略。
逆行入路已被报道用于治疗困难的CTO病变。
本研究评估了96例连续患者的119处CTO病变。这些病变采用顺行入路(A组)或顺行与逆行联合双侧入路(B组)进行治疗。比较了具体的干预技术、院内成功率以及主要不良心脑血管事件(MACCE)。
与A组相比,B组更倾向于选择具有发育良好的间隔侧支且微通道不迂曲的病变(分别为P<0.001和0.008)。与A组相比,B组中位于右冠状动脉的CTO病变更多(P<0.001)。与A组相比,B组的CTO病变长度更长,且需要更硬的导丝来通过病变(分别为P = 0.001和0.046)。A组和B组的技术成功率分别为94%和86%(P = 0.127)。两组的院内并发症无差异。B组比A组需要更高的辐射剂量和更长的照射时间(P<0.001)。在B组中,使用逆行方法显著提高了最终成功率。
这些结果表明,所有CTO病变应首先采用顺行入路进行处理。当通过病变存在困难时,对于侧支发育良好的病变,转换为双侧入路是一种选择。